EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut Roseburia is a protective marker for peritoneal metastasis of gastric cancer

Dandan Yu, Qilin Fan, Jinru Yang, Min Jin, Linli Shi, Bin Zhou, Lei Zhao, Jieying Zhang, Zhenyu Lin iD, Tao Zhang, Hongli Liu iD

Cancer Medicine · 2024-08 · 13 (15)

DOI: 10.1002/cam4.70037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 07.08.2024. Verfasst von Dandan Yu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Gastrointestinal Microbiome, Peritoneal Neoplasms, RNA, Ribosomal, 16S. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific research project of Hubei Provincial Health Commission, Beijing Bethune Public Welfare Foundation, Chinese Society of Clinical Oncology Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gastric cancer (GC), particularly for advanced stage of GC, commonly undergoes peritoneal metastasis (PM), which is the leading cause of GC‐related death. However, there currently has no reliable biomarker to predict the onset of GCPM. It is well known that the imbalance of gut microbiota contributes to the development and metastasis of gastrointestinal tumors. Unfortunately, little is known about how the alternation in gut microbiota is associated with the onset of GCPM.

Methods

Our current study analyzed structural characteristics and functional prediction of gut microbiota in GC patients with PM (PM group) and without PM (non‐PM group). Fresh fecal samples were collected from a discovery cohort (PM = 38, non‐PM = 54) and a validation cohort (PM = 15, non‐PM = 21) of GC patients and their 16S ribosomal RNA (16s rRNA) gene amplicons were sequenced, followed by bioinformatics.

Results

The results indicated an increase in the biodiversity of gut microbiota in the non‐PM group of the discovery cohort, compared with the PM group. Moreover, LEfSe analysis found 31 significantly different microorganisms, of which the Roseburia ranked the fifth in the random forest (RF) model. The characteristics of intestinal microbiota in GCPM patients were changed, and the abundance of Roseburia in gut microbiota from the GCPM patients was reduced and receiver operating characteristic (ROC) analysis revealed that the reduced abundance of gut Roseburia effectively predicted the onset of GCPM.

Conclusion

This signature was also observed in the validation cohort. Therefore, Roseburia is a protective microbial marker and the reduced abundance of Roseburia in gut microbiota may help early diagnosis of GCPM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsGastrointestinal MicrobiomePeritoneal NeoplasmsRNA, Ribosomal, 16SFecesHumansMaleFemaleMiddle AgedBiomarkers, TumorAgedEubacteriales

Stichwörter der Autor:innen

Roseburia16 s rRNA sequencinggastric cancergut microbiomeperitoneal metastasis

Substanzen

RNA, Ribosomal, 16SBiomarkers, Tumor

Autor:innen und Institutionen

  • Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Hubei Key Laboratory of Precision Radiation Oncology, Wuhan, People's Republic of China.
  • Department of Gastroenterology, General Hospital of Central Theater Command, Wuhan, People's Republic of China.

ORCID-Profile: Zhenyu Lin, Hongli Liu

Förderung

  • Scientific research project of Hubei Provincial Health Commission
  • Beijing Bethune Public Welfare Foundation
  • Chinese Society of Clinical Oncology Research Foundation
  • National Natural Science Foundation of China
  • Hubei Xiaoping Chen Science and Technology Development Foundation Jingrui Development Fund

Zitieren

APA

Yu, D., Fan, Q., Yang, J., Jin, M., Shi, L., Zhou, B., Zhao, L., Zhang, J., Lin, Z., Zhang, T., & Liu, H. (2024). Gut Roseburia is a protective marker for peritoneal metastasis of gastric cancer. Cancer Medicine, 13(15). https://doi.org/10.1002/cam4.70037

Vancouver

Yu D, Fan Q, Yang J, Jin M, Shi L, Zhou B, et al. Gut Roseburia is a protective marker for peritoneal metastasis of gastric cancer. Cancer Medicine. 2024;13(15). doi:10.1002/cam4.70037

BibTeX
@article{Yu2024,
  author = {Yu, Dandan and Fan, Qilin and Yang, Jinru and Jin, Min and Shi, Linli and Zhou, Bin and Zhao, Lei and Zhang, Jieying and Lin, Zhenyu and Zhang, Tao and Liu, Hongli},
  title = {Gut Roseburia is a protective marker for peritoneal metastasis of gastric cancer},
  journal = {Cancer Medicine},
  year = {2024},
  volume = {13},
  number = {15},
  doi = {10.1002/cam4.70037}
}
Kostenlos starten →